Elizabeth Anderson
Stock Analyst at Evercore ISI Group
(0.46)
# 2,734
Out of 4,479 analysts
58
Total ratings
22.22%
Success rate
-21.87%
Average return
Main Sectors:
20 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WBA Walgreens Boots Alliance | Maintains: In-Line | $17 → $10 | $11.58 | -13.64% | 11 | Jun 28, 2024 | |
| XRAY DENTSPLY SIRONA | Maintains: Outperform | $35 → $28 | $24.63 | +13.68% | 3 | Jun 25, 2024 | |
| NVST Envista Holdings | Maintains: Outperform | $24 → $19 | $16.11 | +17.94% | 1 | Jun 25, 2024 | |
| ALGN Align Technology | Maintains: Outperform | $370 → $300 | $238.64 | +25.71% | 7 | Jun 10, 2024 | |
| DOCS Doximity | Maintains: In-Line | $28 → $29 | $27.47 | +5.57% | 4 | May 17, 2024 | |
| FTRE Fortrea Holdings | Maintains: Outperform | $43 → $31 | $23.86 | +29.92% | 3 | May 14, 2024 | |
| MCK McKesson | Maintains: Outperform | $590 → $600 | $586.34 | +2.33% | 1 | May 8, 2024 | |
| IQV IQVIA Holdings | Maintains: Outperform | $275 → $250 | $208.49 | +19.91% | 2 | May 3, 2024 | |
| CAH Cardinal Health | Maintains: In-Line | $110 → $115 | $97.76 | +17.64% | 3 | May 3, 2024 | |
| AUGX Augmedix | Upgrades: Outperform | $4.5 → $5 | $0.93 | +437.63% | 3 | Apr 9, 2024 | |
| PRVA Privia Health Group | Maintains: Outperform | $26 → $25 | $17.10 | +46.20% | 2 | Feb 28, 2024 | |
| AGL agilon health | Maintains: In-Line | $7 → $6 | $6.07 | -1.15% | 2 | Feb 28, 2024 | |
| RCM R1 RCM | Downgrades: In-Line | $12 → $16 | $12.56 | +27.39% | 2 | Feb 28, 2024 | |
| HCAT Health Catalyst | Maintains: Outperform | $11 → $10 | $6.07 | +64.74% | 3 | Feb 23, 2024 | |
| LH Labcorp Holdings | Initiates: In-Line | $240 | $203.13 | +18.15% | 1 | Feb 9, 2024 | |
| CVS CVS Health | Upgrades: Outperform | $81 → $83 | $58.15 | +42.73% | 3 | Sep 19, 2023 | |
| DGX Quest Diagnostics | Initiates: In-Line | $159 | $137.09 | +15.98% | 1 | Jan 23, 2023 | |
| GOCO GoHealth | Maintains: In-Line | $68 → $26 | $10.44 | +151.44% | 3 | Mar 16, 2022 | |
| EHTH eHealth | Downgrades: In-Line | $35 → $15 | $4.60 | +226.09% | 2 | Mar 2, 2022 | |
| SLQT SelectQuote | Downgrades: In-Line | $11 | $3.06 | +259.48% | 1 | Jan 4, 2022 |
Walgreens Boots Alliance
Jun 28, 2024
Maintains: In-Line
Price Target: $17 → $10
Current: $11.58
Upside: -13.64%
DENTSPLY SIRONA
Jun 25, 2024
Maintains: Outperform
Price Target: $35 → $28
Current: $24.63
Upside: +13.68%
Envista Holdings
Jun 25, 2024
Maintains: Outperform
Price Target: $24 → $19
Current: $16.11
Upside: +17.94%
Align Technology
Jun 10, 2024
Maintains: Outperform
Price Target: $370 → $300
Current: $238.64
Upside: +25.71%
Doximity
May 17, 2024
Maintains: In-Line
Price Target: $28 → $29
Current: $27.47
Upside: +5.57%
Fortrea Holdings
May 14, 2024
Maintains: Outperform
Price Target: $43 → $31
Current: $23.86
Upside: +29.92%
McKesson
May 8, 2024
Maintains: Outperform
Price Target: $590 → $600
Current: $586.34
Upside: +2.33%
IQVIA Holdings
May 3, 2024
Maintains: Outperform
Price Target: $275 → $250
Current: $208.49
Upside: +19.91%
Cardinal Health
May 3, 2024
Maintains: In-Line
Price Target: $110 → $115
Current: $97.76
Upside: +17.64%
Augmedix
Apr 9, 2024
Upgrades: Outperform
Price Target: $4.5 → $5
Current: $0.93
Upside: +437.63%
Privia Health Group
Feb 28, 2024
Maintains: Outperform
Price Target: $26 → $25
Current: $17.10
Upside: +46.20%
agilon health
Feb 28, 2024
Maintains: In-Line
Price Target: $7 → $6
Current: $6.07
Upside: -1.15%
R1 RCM
Feb 28, 2024
Downgrades: In-Line
Price Target: $12 → $16
Current: $12.56
Upside: +27.39%
Health Catalyst
Feb 23, 2024
Maintains: Outperform
Price Target: $11 → $10
Current: $6.07
Upside: +64.74%
Labcorp Holdings
Feb 9, 2024
Initiates: In-Line
Price Target: $240
Current: $203.13
Upside: +18.15%
CVS Health
Sep 19, 2023
Upgrades: Outperform
Price Target: $81 → $83
Current: $58.15
Upside: +42.73%
Quest Diagnostics
Jan 23, 2023
Initiates: In-Line
Price Target: $159
Current: $137.09
Upside: +15.98%
GoHealth
Mar 16, 2022
Maintains: In-Line
Price Target: $68 → $26
Current: $10.44
Upside: +151.44%
eHealth
Mar 2, 2022
Downgrades: In-Line
Price Target: $35 → $15
Current: $4.60
Upside: +226.09%
SelectQuote
Jan 4, 2022
Downgrades: In-Line
Price Target: $11
Current: $3.06
Upside: +259.48%